INTERNATIONAL JOURNAL OF OBESITY

INTERNATIONAL JOURNAL OF OBESITY(英文缩写 INT J OBESITY),ISSN 0307-0565,eISSN 1476-5497 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
5.400
JCR 分区
Q1
CAS 分区
B2
近一年发文量
368
本站 PubMed 收录统计

发文量统计区间:2025-09-21 至 2026-09-21,按本站收录文献的发表日期统计。

指标来源:jcr_cas_ifqb

ISSN: 0307-0565 · eISSN: 1476-5497 · 缩写: INT J OBESITY

期刊简介

暂无简介。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
20215.551Q2
20224.900Q2
20234.200Q1
20243.800Q2
20255.400Q1

INTERNATIONAL JOURNAL OF OBESITY 最新收录文献

  1. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    1. Deep learning-derived abdominal adiposity phenotypes and 28-day mortality in sepsis.

    作者:
    Hye Ju Yeo, Ha Lim Kim, Kipoong Kim, Jin Ho Jang, Eunjeong Choi, Hee Yun Seol, Seung Eun Lee, Woo Hyun Cho
    日期:
    2026-09-19

    Body mass index does not distinguish visceral from subcutaneous adiposity, which may have different prognostic implications during sepsis. We used automated computed tomography (CT) analysis to evaluate the associations of abdominal adipose tissue distribution with 28-day mortality. In this single-c…

  2. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    2. Effects of nocturnal intermittent hypoxia on metabolic syndrome in Japanese adults without abdominal obesity.

    作者:
    Yuko Kato, Ai Ikeda, Hadrien Charvat, Kiyohide Tomooka, Koutatsu Maruyama, Isao Saito, Takeshi Tanigawa
    日期:
    2026-09-19

    The association between nocturnal intermittent hypoxia and metabolic syndrome (MetS) in individuals without abdominal obesity has not yet been fully explored. We conducted a longitudinal study to investigate the association between nocturnal intermittent hypoxia and the incidence of MetS and its com…

  3. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    3. Levothyroxine therapy for euthyroidism restoration results in clinically insignificant weight and anthropometric changes: a systematic review and meta-analysis.

    作者:
    Sium Wolde Sellasie, Nicola Ossola, Tommaso Piticchio, Luigi Uccioli, Pierpaolo Trimboli
    日期:
    2026-09-18

    Weight gain is commonly regarded as a hallmark of hypothyroidism,although supporting evidence is limited. Consequently, restoration of euthyroidism with levothyroxine is often expected to induce clinically meaningful weight loss or return to premorbid body weight. These expectations may affect patie…

  4. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    4. Association of trimester-specific gestational weight gain with child BMI by maternal BMI categories in community-based healthcare organizations.

    作者:
    Erin S LeBlanc, Rachel Springer, Anna Booman, Natalie A Rosenquist, Kimberly K Vesco, Evelyn Sun, Byron A Foster, Janne Boone-Heinonen
    日期:
    2026-09-17

    Information is lacking about how trimester-specific gestational weight gain (GWG) is associated with childhood body mass index (BMI) across maternal BMI categories. We examined the association between GWG and child BMI in patients receiving care from a national network of community health care organ…

  5. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    5. Body mass index and regional brain N-acetylaspartate: a systematic review and meta-analysis of ¹H-MRS studies.

    作者:
    Cameron MacGillivray, Linzhi Wu, Julia Fraiha-Pegado, Sean McWhinney, Tomas Hajek
    日期:
    2026-09-15

    Obesity has increasingly been associated with structural brain alterations and cognitive dysfunction; however, the neurometabolic correlates of these findings remain unclear. Proton magnetic resonance spectroscopy (H-MRS) provides a non-invasive method for examining neurometabolites in vivo, includi…

  6. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    6. Changes in plasma levels of a selected panel of miRNAs do not explain the shift from cholesterol-synthesizer to cholesterol-absorber phenotype in men with abdominal obesity after diet-induced weight loss.

    作者:
    Maurice C J M Konings, Ronald P Mensink, Peter J Joris, Mark V Boekschoten, Casper G Schalkwijk, Alfons J H M Houben, Jogchum Plat
    日期:
    2026-09-15

    Individuals with overweight or obesity exhibit a cholesterol-synthesizer phenotype (high plasma lathosterol/campesterol ratio). Previously, we have reported that weight loss in men with abdominal obesity shifted this phenotype towards a cholesterol-absorber (low plasma ratio) profile. Given the role…

  7. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    7. Sociodemographic and socioeconomic differences in the use of anti-obesity medications: a register study among 282,307 Finnish adults.

    作者:
    Jatta Valkonen, Anna Christina Svärd, Eira Roos, Anu Joki, Anne Kouvonen, Tea Lallukka
    日期:
    2026-09-09

    The use of anti-obesity medications (AOMs) has remarkably increased in recent years globally, yet little is known about how sociodemographic and socioeconomic factors are associated with their use in Finland or in any Nordic countries. This study examined these associations in a large Finnish adult …

  8. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    8. Causal adiposity and clinical validation of regional fat distribution in PMOS: a multi-modal analysis integrating GBD 2021, Mendelian randomization, and machine learning.

    作者:
    Guohong Zhao, Yuxin Jin, Aili Yang, Xinwen Yu, Zhenhong Yan, Shanshan Zhu, Shuo Yang, Weiting Wang, Bin Gao
    日期:
    2026-09-07

    Polyendocrine metabolic ovarian syndrome (PMOS), previously named polycystic ovary syndrome (PCOS), is the most common endocrine disorder among women of reproductive age and a leading cause of anovulatory infertility. However, the evolving global burden of PMOS and the role of adiposity, particularl…

  9. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    9. Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.

    作者:
    Agostino Milluzzo, Vittorio Oteri, Lucia Manuella, Alfredo Pulvirenti, Lucia Frittitta
    日期:
    2026-08-29

    Obesity is a chronic, relapsing disease associated with multiple serious comorbidities. Semaglutide has emerged as an effective pharmacological option for obesity management, owing to its substantial effects on weight loss, cardiometabolic risk factors, and patient-reported outcomes. This systematic…

  10. JCR分区: Q1 CAS分区: B2 影响因子: 5.4

    10. Identification of cognitive factors that predict behavioural weight-loss intervention outcomes.

    作者:
    Golnaz Arjmand, Filip M Morys, Justin J Sung, Chavonn C Duncan, Xue S Davis, Shilan Heshmati, Xi Fang, Marney A White, Carlos M Grilo, Dana M Small
    日期:
    2026-08-29

    Individuals vary widely in their response to behavioral weight-loss interventions, suggesting that neurocognitive differences may influence treatment success. We examined whether baseline cognitive performance predicted percent change in body weight over 8 months in a behavioral weight-loss trial. T…

在 INTERNATIONAL JOURNAL OF OBESITY 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊